Their team at the WTC Amsterdam currently consists of about 10 employees, but their numbers are growing quickly. The Amsterdam office will bear overall responsibility for Business Development, Legal & Regulatory Affairs, Marketing & Sales, and Human Resources.
Expanding its global footprint
Leader Biomedical’s mission is to bring its portfolio of biomaterials and medical implants to high-growth markets. In the last two years, its diverse and dedicated team has been working towards realising this mission by setting up offices in Amsterdam, Hong Kong, Shanghai, and Bangalore, and is currently in the process of expanding to São Paulo. The company’s global expansion is further supported by acquisitions such as the purchase of the Nijmegen-based biomaterials manufacturer European Medical Contract Manufacturing (EMCM) in 2014.
"Through hard work and dedication, we’ve been able to move quickly, and I am very pleased with the progress we have made,” said Professor Lugee Li, Leader Biomedical’s founder. “This is however only the beginning, and you can expect more exciting news in the near future."
Amsterdam the right choice for the life sciences
It is no surprise that Leader Biomedical chose to set up shop in Amsterdam. The Amsterdam Metropolitan Area is the Netherlands' leading region for life sciences research. It is home to two respected universities, academic hospitals, and many specialised research institutes. This ensures superb access to innovative technologies, clinical trials, biobanks, and centres of expertise. These companies are aided by hundreds of specialised partners in financial & business services, ICT, and logistics.